The scientific enterprise is facing significant challenges due to recent administrative policies that are severely limiting indirect grant costs, disrupting research funding, limiting communication with federal agencies, and delaying critical grant review processes. These changes are already having real and immediate impacts on labs, research institutions, and the broader biomedical innovation ecosystem.

We need your voice. AIMBE has posted a public statement on these critical issues and developed two advocacy letters, below, that you can easily customize and send to your congressional representatives to urge them to protect research funding, ensure open collaboration, and support biomedical innovation.

AIMBE Statement on the Impact of Federal Policy Changes on Biomedical Research